查找临床试验
已按「黑色素瘤」检索，对应国际通用词 melanoma
共找到 64 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步正在招募I 期 / II 期中国有中心NCT07371663
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
China
年龄 18 Years – 不限
Beijing Tide Pharmaceutical Co., Ltd
正在招募III 期中国有中心NCT06008106
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
China
年龄 18 Years – 不限
Shanghai Kechow Pharma, Inc.
正在招募I 期中国有中心NCT05366478
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
China
年龄 18 Years – 不限
Suzhou BlueHorse Therapeutics Co., Ltd.
正在招募I 期 / II 期NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Daiichi Sankyo
正在招募I 期 / II 期中国有中心NCT07070518
Study of GV20-0251 in Participants With Solid Tumor Malignancies
China
年龄 18 Years – 不限
GV20 Therapeutics
正在招募I 期中国有中心NCT06942143
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
China
年龄 18 Years – 75 Years
Guangzhou FineImmune Biotechnology Co., LTD.
正在招募I 期中国有中心NCT07260591
VSV-02 Compassionate Use in Advanced Solid Tumors
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xinxiang Medical College
正在招募I 期 / II 期中国有中心NCT07410676
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
China
年龄 不限 – 不限
Essen Biotech
正在招募I 期 / II 期中国有中心NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
United States、Australia、Belgium、China、Germany 等 9 国
年龄 18 Years – 不限
BioNTech SE
正在招募I 期中国有中心NCT07177937
A Study of DXC014 in Patients With Advanced Solid Tumors.
China
年龄 18 Years – 不限
Hangzhou DAC Biotechnology Co., Ltd.
正在招募I 期 / II 期中国有中心NCT05983237
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
China
年龄 18 Years – 不限
Jun Guo
正在招募不适用中国有中心NCT07760012
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
China
年龄 18 Years – 不限
Peking University Third Hospital